Novel lectin-modified poly(ethylene-co-vinyl acetate) mucoadhesive nanoparticles of carvedilol: preparation and in vitro optimization using a two-level factorial design

References

• Frishman WH. Carvedilol. Drug Therapy 1998;339:1759–1765
   Google Scholar
• Giessmann T, Modess C, Hecker U, et al. CYP2D6 genotype and induction of intestinal drug transporters by rifampin predict presystemic clearance of carvedilol in healthy subjects. Clin Pharmacol Ther 2004;75:213–222
   PubMed Web of Science ®Google Scholar
• Vishnu YV, Chandrasekhar K, Ramesh G, Rao YM. Development of mucoadhesive patches for buccal administration of carvedilol. Curr Drug Deliv 2007;4:27–39
   PubMedGoogle Scholar
• Varshosaz J, Minayian M, Moazen E. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles. J Liposome Res 2010;20:115–123
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Tabbakhian M, Yegane Mohammadi M. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability. J Liposome Res 2010;20:286–296
   PubMed Web of Science ®Google Scholar
• Humberstone AJ, Charman WN. Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 1997;25:103–128
   Web of Science ®Google Scholar
• Yuan H, Chen J, Du YZ, et al. Studies on oral absorption of stearic acid SLN by a novel fluorometric method. Colloids Surf B: Biointerfaces 2007;58:157–164
   PubMed Web of Science ®Google Scholar
• Bargoni A, Cavalli R, Caputo O, et al. Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. Pharm Res 1998;15:745–750
   PubMed Web of Science ®Google Scholar
• Chen H, Torchilin V, Langer R. Lectin bearing polymerized liposomes as potential oral vaccine carriers. Pharm Res 1996;13:1378–1383
   PubMed Web of Science ®Google Scholar
• Gupta PN, Mahor S, Rawat A, et al. M-cell targeted biodegradable nanoparticles containing Hepatitis B surface antigen. Proceeding of the 32nd Annual Meeting and Exposition of the Controlled Release Society, Florida; 2005:195
   Google Scholar
• Vyas SP, Singh A, Sihorkar V. Ligand-receptor-mediated drug delivery: an emerging paradigm in cellular drug targeting. Crit Rev Ther Drug Carrier Syst 2001;18:1–76
   PubMed Web of Science ®Google Scholar
• Kumar M, Behera AK, Kumar S, et al. Expression, purification and characterization of peanut (Arachis hypogaea) agglutinin (PNA) from baculovirus infected insect cells. Biosci Rep 1999;19:227–234
   PubMedGoogle Scholar
• Ponchel G, Irache J. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev 1998;34:191–219
   PubMed Web of Science ®Google Scholar
• Venishetty VK, Chede R, Komuravelli R, et al. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration. Colloids Surf B Biointerfaces 2012;95:1–9
   PubMed Web of Science ®Google Scholar
• Liu D, Xu H, Tian B, et al. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation--ultrasonication method for the improvement of dissolution rate and oral bioavailability. AAPS PharmSciTech 2012;13:295–304
   PubMed Web of Science ®Google Scholar
• Chakraborty S, Shukla D, Vuddanda PR, et al. Effective in-vivo utilization of lipid-based nanoparticles as drug carrier for carvedilol phosphate. J Pharm Pharmacol 2011;63:774–779
   PubMed Web of Science ®Google Scholar
• Sanjula B, Shah FM, Javed A, Alka A. Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement. J Drug Target 2009;17:249–256
   PubMed Web of Science ®Google Scholar
• Yamsani VV, Gannu R, Kolli C, et al. Development and in vitro evaluation of buccoadhesive carvedilol tablets. Acta Pharm 2007;57:185–197
   PubMedGoogle Scholar
• Vishnu YV, Chandrasekhar K, Ramesh G, Rao YM. Development of mucoadhesive patches for buccal administration of carvedilol. Curr Drug Deliv 2007;4:27–39
   PubMedGoogle Scholar
• Cappello B, De Rosa G, Giannini L, et al. Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system. Int J Pharm 2006;319:63–70
   PubMed Web of Science ®Google Scholar
• Cypesa SH, Saltzmanb WM, Giannelis EP. Organosilicate-polymer drug delivery systems: controlled release and enhanced mechanical properties. J Control Rel 2003;90:163–169
   PubMedGoogle Scholar
• Park JH, Cho YW, Cho YH, et al. Norfloxacin-releasing urethral catheter for long-term catheterization. J Biomater Sci Polym Ed 2003;14:951–962
   PubMed Web of Science ®Google Scholar
• Lee WL, Widjaja E, Loo SC. One-step fabrication of triple-layered polymeric microparticles with layer localization of drugs as a novel drug-delivery system. Small 2010;6:1003–1011
   PubMed Web of Science ®Google Scholar
• de Queiroz AA, Abraham GA, Higa OZ. Controlled release of 5-fluorouridine from radiation-crosslinked. poly(ethylene-co-vinyl acetate) films. Acta Biomater 2006;2:641–650
   PubMed Web of Science ®Google Scholar
• Keskar V, Mohanty PS, Gemeinhart EJ, Gemeinhart RA. Cervical cancer treatment with a locally insertable controlled release delivery system. J Control Rel 2006;115:280–288
   PubMed Web of Science ®Google Scholar
• Beeley NRF, Stewart JM, Tano R, et al. Development, implantation, in vivo elution, and retrieval of a biocompatible, sustained release subretinal drug delivery system. J Biomed Mater Res 2006;76A:690–698
   Google Scholar
• Khajavinia A, Varshosaz J, Jafarian Dehkordy A. Targeting etoposide to acute myelogenous leukemia cells using nanostructured lipid carriers surface modified with transferring. Nanotechnology 2012;23:405101
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein--dye binding. Anal Biochem 1976;72:248–254
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Dehghan Z. Development and characterization of buccoadhesive nifedipine tablets. Eur J Pharm Biopharm 2002;54:135–141
   PubMed Web of Science ®Google Scholar
• He P, Davis SS, Illum L. In vitro evaluation of mucoadhesive properties of chitosan microspheres. Int J Pharm 1998;166:75–88
   Web of Science ®Google Scholar
• McPolin O. Validation of analytical methods for pharmaceutical analysis. Northern Ireland: Mourne Training Services, 2009:73--84
   Google Scholar
• Averineni RK, Shavi GV, Gurram AK, et al. PLGA 50:50 nanoparticles of paclitaxel: development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation. Bull Mater Sci 2012;35:319–326
   Web of Science ®Google Scholar
• Mammadpour Dounighi N, Eskandari R, Avadi MR, et al. Preparation and in vitro characterization of chitosan nanoparticles containing Mesobuthus eupeus scorpion venom as an antigen delivery system. J Venom Anim Toxins incl Trop Dis 2012;18:44–52
   Google Scholar
• Zhang Q, Lin W, Yang G, Chen Q. Studies on the phase structure of ethylenevinyl acetate copolymers by solid-stage 1H and 13C NMR. J Polym Sci: Part B: Polym Phys 2002;40:2199–2207
   Google Scholar
• Brogly M, Nardin M, Schultz J. Effect of vinyl acetate content on crystallinity and second-order transitions in ethylene-vinylacetate copolymers. J Appl Polym Sci 1997;64:1903–1912
   Web of Science ®Google Scholar
• Tallury P, Alimohammadi N, Kalachandra S. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate. Dent Mat 2007;23:404–409
   PubMed Web of Science ®Google Scholar
• Fattahi A, Golozar MA, Varshosaz J, et al. Preparation and characterization of micelles of oligomeric chitosan linked to all-trans retinoic acid. Carbohyd Polym 2012;87:1176–1184
   Web of Science ®Google Scholar
• Na K, Park KH, Kim SW, Bae YH. Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with a hepatoma cell line (HepG2). J Control Rel 2000;69:225–236
   PubMed Web of Science ®Google Scholar
• Gowthamarajan K, Singh SK. Dissolution testing for poorly soluble drugs: a continuing perspective. Dissolu Technol 2010;17:24–32
   Web of Science ®Google Scholar
• Gupta A, Gaud RS, Ganga S. Development of discriminating dissolution method for an insoluble drug: nisoldipine. Int J PharmTech Res 2010;2:931–939
   Google Scholar
• Jamsad S, Fassihi R. Role of surfactant and pH on dissolution properties of fenofibrate and glipiside – a technical note. AAPS PharmSciTech 2006;7:17–22
   Google Scholar
• Fortunato D. Dissolution method development for immediate release solid oral dosage forms. Dissolut Technol 2005;12:12–14
   Google Scholar
• Kim D, Choi C, Jeong Y, et al. All-trans retinoic acid-associated low molecular weight water-soluble chitosan nanoparticles based on ion complex. Macromol Res 2006;14:66–72
   Web of Science ®Google Scholar
• Bayomi MA. Aqueous preparation and evaluation of albumin-chitosan microspheres containing indomethacin. Drug Dev Indust Pharm 2004;30:329–339
   PubMed Web of Science ®Google Scholar
• Murali Mohan Babu GV, Prasad DS, Narayan CPS, Ramana Murthy KV. New system for microencapsulation of diclofenac sodium using gum karaya and chitosan. Saudi Pharm J 2001;9:169–178
   Google Scholar
• Bogataj M, Vovk T, Kerec M, et al. The correlation between zeta potential and mucoadhesion strength on pig vesical mucosa. Biol Pharm Bull 2003;26:743–746
   PubMed Web of Science ®Google Scholar
• Norris DA, Sinko PJ. Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. J Appl Polym Sci 1997;63:1481–1492
   Web of Science ®Google Scholar
• Kesisoglou F, Panmai S, Wu Y. Nanosizing – oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 2007;59:631–644
   PubMed Web of Science ®Google Scholar
• Vighi E, Ruozi B, Montanari M, et al. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid. Eur J Pharm Biopharm 2007;67:320–328
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B, et al. Physico-chemical stability of colloidal lipid particles. Biomaterials 2003;24:4283–4300
   PubMed Web of Science ®Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles production, characterization and applications. Adv Drug Deliv Rev 2001;47:165–196
   PubMed Web of Science ®Google Scholar
• Nag A, Das S. Effect of trehalose and lactose as cryoprotectant during freeze-drying, in vitro gastro-intestinal transit and survival of microencapsulated freeze-dried Lactobacillus casei 431 cells. Int J Dairy Technol 2013;6:162–169
   Google Scholar
• Varshosaz J, Eskandari S, Tabbakhian M. Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants. Carbohyd Polym 2012;88:1157–1163
   Web of Science ®Google Scholar
• Salyer IO, Kenyon AS. Structure and property relationships in ethylene-vinyl acetate copolymers. J Polym Sci 1971;9:3083–3103
   Web of Science ®Google Scholar